Latest news with #NicholasYulico
Business Insider
16-07-2025
- Business
- Business Insider
Boston Properties (BXP) Receives a Hold from Morgan Stanley
Morgan Stanley analyst Ronald Kamdem maintained a Hold rating on Boston Properties today and set a price target of $65.00. The company's shares closed today at $69.92. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Kamdem covers the Real Estate sector, focusing on stocks such as Macerich, Realty Income, and Gaming and Leisure. According to TipRanks, Kamdem has an average return of 4.1% and a 53.11% success rate on recommended stocks. In addition to Morgan Stanley, Boston Properties also received a Hold from Scotiabank's Nicholas Yulico in a report issued yesterday. However, on the same day, Mizuho Securities maintained a Buy rating on Boston Properties (NYSE: BXP). Based on Boston Properties' latest earnings release for the quarter ending March 30, the company reported a quarterly revenue of $865.22 million and a net profit of $61.18 million. In comparison, last year the company earned a revenue of $839.44 million and had a net profit of $79.88 million
Yahoo
13-05-2025
- Business
- Yahoo
Ventas price target lowered to $71 from $72 at Scotiabank
Scotiabank analyst Nicholas Yulico lowered the firm's price target on Ventas (VTR) to $71 from $72 and keeps a Sector Perform rating on the shares. The firm is adjusting its estimates on U.S. Real Estate & REITs in its coverage following Q1 results, the analyst tells investors. Quarterly results contained some negative surprises, but generally played out as expected, with most companies maintaining FY25 guidance, the firm notes. Real estate fundamentals tend to lag, so many are looking to see the potential impact of the slowing economy on H2 2025 results, the firm adds. Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter. Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on VTR: Disclaimer & DisclosureReport an Issue Ventas Inc: Strong Q1 2025 Performance in Senior Housing Ventas Inc. Highlights Strong Q1 Performance and Growth Ventas price target raised to $79 from $78 at Wedbush Welltower price target raised to $169 from $167 at Wedbush Strong Q1 2025 Performance and Strategic Acquisitions Justify Buy Rating for Ventas
Yahoo
13-05-2025
- Business
- Yahoo
Terreno Realty price target raised to $61 from $57 at Scotiabank
Scotiabank analyst Nicholas Yulico raised the firm's price target on Terreno Realty (TRNO) to $61 from $57 and keeps a Sector Perform rating on the shares. The firm is adjusting its estimates on U.S. Real Estate & REITs in its coverage following Q1 results, the analyst tells investors. Quarterly results contained some negative surprises, but generally played out as expected, with most companies maintaining FY25 guidance, the firm notes. Real estate fundamentals tend to lag, so many are looking to see the potential impact of the slowing economy on H2 2025 results, the firm adds. Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter. Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on TRNO: Disclaimer & DisclosureReport an Issue Terreno Realty price target lowered to $61 from $67 at Baird Balanced Outlook: Hold Rating for Terreno Realty Amid Strong Performance and Cautious Economic Concerns Terreno Realty: Strategic Positioning and Operational Strengths Justify Buy Rating Terreno Realty Approves 2025 Equity Incentive Plan TRNO Earnings Report this Week: Is It a Buy, Ahead of Earnings? Sign in to access your portfolio
Yahoo
13-05-2025
- Business
- Yahoo
Prologis price target raised to $100 from $97 at Scotiabank
Scotiabank analyst Nicholas Yulico raised the firm's price target on Prologis (PLD) to $100 from $97 and keeps an Underperform rating on the shares. The firm is adjusting its estimates on U.S. Real Estate & REITs in its coverage following Q1 results, the analyst tells investors. Quarterly results contained some negative surprises, but generally played out as expected, with most companies maintaining FY25 guidance, the firm notes. Real estate fundamentals tend to lag, so many are looking to see the potential impact of the slowing economy on H2 2025 results, the firm adds. Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter. Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on PLD: Disclaimer & DisclosureReport an Issue Prologis Issues $1.25 Billion in Senior Notes Prologis price target lowered to $120 from $126 at Baird Prologis price target lowered to $120 from $123 at Truist Prologis price target lowered to $119 from $132 at Barclays Prologis price target lowered to $117 from $128 at RBC Capital
Yahoo
13-05-2025
- Business
- Yahoo
Sabra Health Care price target raised to $19 from $18 at Scotiabank
Scotiabank analyst Nicholas Yulico raised the firm's price target on Sabra Health Care (SBRA) to $19 from $18 and keeps a Sector Perform rating on the shares. The firm is adjusting its estimates on U.S. Real Estate & REITs in its coverage following Q1 results, the analyst tells investors. Quarterly results contained some negative surprises, but generally played out as expected, with most companies maintaining FY25 guidance, the firm notes. Real estate fundamentals tend to lag, so many are looking to see the potential impact of the slowing economy on H2 2025 results, the firm adds. Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter. Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on SBRA: Disclaimer & DisclosureReport an Issue Sabra Health Care REIT Reports Strong Q1 2025 Results Sabra Healthcare REIT Reports Record Highs and Strong Pipeline Hold Rating on Sabra Healthcare REIT Amid Strong Financials and Strategic Uncertainties Sabra Healthcare REIT Expands Senior Housing Portfolio Sabra Health Care reports Q1 FFO 37c, consensus 36c
